ID

20813

Beschreibung

This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC (Hormone refractory prostate cancer / Castrate resistant prostate cancer) patients diagnosed with bone metastasis and to collect additional short and long term safety data on the product. NCT01618370

Stichworte

  1. 20/3/17 20/3/17 -
Hochgeladen am

20 de marzo de 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Radium-223 Dichloride (Alpharadin) DRKS00006460 NCT01618370 in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases (Study Medication)

Radium 223 Dichloride (Alpharadin) - Study Medication

Study Drug Exposure, radioactive material
Beschreibung

Study Drug Exposure, radioactive material

Did the subject take any Study Drug?
Beschreibung

Study drug

Datentyp

boolean

Alias
UMLS CUI [1]
C0304229
Study drug
Beschreibung

Study drug

Datentyp

text

Alias
UMLS CUI [1]
C0304229
Assessment period
Beschreibung

Assessment period

Datentyp

text

Alias
UMLS CUI [1,1]
C0220825
UMLS CUI [1,2]
C1948053
Start Date
Beschreibung

Start Date

Datentyp

date

Alias
UMLS CUI [1]
C0808070
Start time
Beschreibung

(24-hour clock)

Datentyp

time

Alias
UMLS CUI [1]
C1301880
Stop Date
Beschreibung

Stop Date

Datentyp

date

Alias
UMLS CUI [1]
C0806020
Planned dose
Beschreibung

Planned dose

Datentyp

text

Maßeinheiten
  • kBq/kg body weight
Alias
UMLS CUI [1]
C2826283
kBq/kg body weight
Weight
Beschreibung

Weight

Datentyp

float

Maßeinheiten
  • kg
Alias
UMLS CUI [1]
C0005910
kg
Decay Correction factor
Beschreibung

Decay Correction factor

Datentyp

text

Alias
UMLS CUI [1]
C3166265
Declared activity of Study Drug
Beschreibung

Declared activity of Study Drug

Datentyp

text

Maßeinheiten
  • kBq/mL
Alias
UMLS CUI [1,1]
C3854006
UMLS CUI [1,2]
C0599112
kBq/mL
Calculated Volume to be injected
Beschreibung

Volume

Datentyp

text

Maßeinheiten
  • ml
Alias
UMLS CUI [1,1]
C0449468
UMLS CUI [1,2]
C0444686
ml
Calculated Radioactivity to be injected
Beschreibung

Calculated Radioactivity

Datentyp

text

Maßeinheiten
  • kBq
Alias
UMLS CUI [1,1]
C0444686
UMLS CUI [1,2]
C0034553
kBq
Actual volume in syringe before injection
Beschreibung

volume in syringe before injection

Datentyp

text

Maßeinheiten
  • ml
Alias
UMLS CUI [1,1]
C4071537
UMLS CUI [1,2]
C0585032
ml
Radioactivity in syringe before injection
Beschreibung

Radioactivity in syringe

Datentyp

text

Maßeinheiten
  • kBq
Alias
UMLS CUI [1,1]
C0034553
UMLS CUI [1,2]
C1706071
UMLS CUI [1,3]
C0585032
kBq
Radioactivity in syringe after injection
Beschreibung

Radioactivity in syringe

Datentyp

text

Maßeinheiten
  • kBq
Alias
UMLS CUI [1,1]
C0034553
UMLS CUI [1,2]
C1706071
UMLS CUI [1,3]
C0580203
kBq
Actual volume in syringe after injection
Beschreibung

volume in syringe after injection

Datentyp

text

Maßeinheiten
  • ml
Alias
UMLS CUI [1,1]
C4071537
UMLS CUI [1,2]
C0580203
ml
Dose modification 1
Beschreibung

Dose modification

Datentyp

text

Alias
UMLS CUI [1]
C1707811
Reason for dose modification 1
Beschreibung

Dose modification reason

Datentyp

text

Alias
UMLS CUI [1,1]
C1707811
UMLS CUI [1,2]
C0392360
If Adverse event, select up to 3 most important AEs:
Beschreibung

Dynamic search list contains: "Number - Term - Start Date"

Datentyp

text

Alias
UMLS CUI [1]
C0877248
If Other, specify
Beschreibung

If Other, specify

Datentyp

text

Alias
UMLS CUI [1]
C3840932

Ähnliche Modelle

Radium 223 Dichloride (Alpharadin) - Study Medication

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Study Drug Exposure, radioactive material
Study drug
Item
Did the subject take any Study Drug?
boolean
C0304229 (UMLS CUI [1])
Study drug
Item
Study drug
text
C0304229 (UMLS CUI [1])
Assessment period
Item
Assessment period
text
C0220825 (UMLS CUI [1,1])
C1948053 (UMLS CUI [1,2])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1])
Start time
Item
Start time
time
C1301880 (UMLS CUI [1])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1])
Planned dose
Item
Planned dose
text
C2826283 (UMLS CUI [1])
Weight
Item
Weight
float
C0005910 (UMLS CUI [1])
Decay Correction factor
Item
Decay Correction factor
text
C3166265 (UMLS CUI [1])
Declared activity of Study Drug
Item
Declared activity of Study Drug
text
C3854006 (UMLS CUI [1,1])
C0599112 (UMLS CUI [1,2])
Volume
Item
Calculated Volume to be injected
text
C0449468 (UMLS CUI [1,1])
C0444686 (UMLS CUI [1,2])
Calculated Radioactivity
Item
Calculated Radioactivity to be injected
text
C0444686 (UMLS CUI [1,1])
C0034553 (UMLS CUI [1,2])
volume in syringe before injection
Item
Actual volume in syringe before injection
text
C4071537 (UMLS CUI [1,1])
C0585032 (UMLS CUI [1,2])
Radioactivity in syringe
Item
Radioactivity in syringe before injection
text
C0034553 (UMLS CUI [1,1])
C1706071 (UMLS CUI [1,2])
C0585032 (UMLS CUI [1,3])
Radioactivity in syringe
Item
Radioactivity in syringe after injection
text
C0034553 (UMLS CUI [1,1])
C1706071 (UMLS CUI [1,2])
C0580203 (UMLS CUI [1,3])
volume in syringe after injection
Item
Actual volume in syringe after injection
text
C4071537 (UMLS CUI [1,1])
C0580203 (UMLS CUI [1,2])
Dose modification
Item
Dose modification 1
text
C1707811 (UMLS CUI [1])
Dose modification reason
Item
Reason for dose modification 1
text
C1707811 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Adverse event
Item
If Adverse event, select up to 3 most important AEs:
text
C0877248 (UMLS CUI [1])
If Other, specify
Item
If Other, specify
text
C3840932 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video